Combination therapy with an angiotensin‐converting‐enzyme inhibitor and an angiotensin II receptor antagonist ameliorates microinflammation and oxidative stress in patients with diabetic nephropathy

AIMS/INTRODUCTION: Recent studies have pointed to the effectiveness of combination therapy with an angiotensin‐converting‐enzyme inhibitor (ACEI) and an angiotensin receptor blocker (ARB) for diabetic nephropathy. However, some controversy over this combination treatment remains and the mechanisms u...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakamura, Akihiko, Shikata, Kenichi, Nakatou, Tatsuaki, Kitamura, Takuya, Kajitani, Nobuo, Ogawa, Daisuke, Makino, Hirofumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley-Blackwell 2012
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4019275/
https://www.ncbi.nlm.nih.gov/pubmed/24843652
http://dx.doi.org/10.1111/jdi.12004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4019275/
https://www.ncbi.nlm.nih.gov/pubmed/24843652
http://dx.doi.org/10.1111/jdi.12004

Ejemplares similares